SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?

To: arnie h who wrote (641)4/8/1998 2:31:00 PM
From: Ken Adams  Read Replies (1) | Respond to of 998
 
To All...

I've been lurking here for a couple weeks. I find the exchange very interesting. I'm looking for a consensus opinion, and it would seem most of you are going to "hold and hope".

I got into CEPH strictly on a technical play. Believe me, the Monday bombshell was quite a shock. I've always told myself the chart knows it all, shows it all. But, that sure as heck wasn't true this time around.

Assuming things work out OK here, how long should I expect to have to hold to "get well"?

Ken



To: arnie h who wrote (641)4/8/1998 5:58:00 PM
From: Cary S. Kart  Read Replies (1) | Respond to of 998
 
Believe you are correct on Provigil. Some would argue that CEPH is a buy at these levels just on the basis of that drug. Friend told me that he remembers reading that some 15-18 US Senators have signed a petition calling for approval of Myotrophin. Any idea on whether this is so?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News